A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer


Study Number
78118
Phase
III
Purpose

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.

Full Title

Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

ClinicalTrials.Gov ID
NCT03574571

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.